GlassScriptPhysician profile
Lillian Katz
NPI 1679768097
$2,985.66
in general payments reported to CMS, 2019-2025
30 companies · $1,397 in 2025
The $1,397 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.58 · 2022: $129 · 2023: $303 · 2024: $1,095 · 2025: $1,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,633 · Education: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,632.73 |
| Education | $162.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $485.62 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $468.92 | 2022-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $394.38 | 2021-2025 | |
| Novo Nordisk INC | $192.04 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Regeneron Healthcare Solutions, INC. | $174.94 | 2022-2025 | Dupixent |
| Sanofi-Aventis U.S. LLC | $135.48 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.25 | 2022-2025 | Jardiance, Ofev, Jascayd |
| Exact Sciences Corporation | $105.72 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $94.07 | 2024-2025 | Freestyle Libre 3 |
| Amgen INC. | $78.03 | 2024-2025 | Tezspire |
| Madrigal Pharmaceuticals | $75.67 | 2025 | Rezdiffra |
| Bayer Healthcare Pharmaceuticals INC. | $73.40 | 2024-2025 | |
| Viatris Specialty LLC | $68.23 | 2025 | Yupelri |
| Insmed, INC. | $66.92 | 2025 | Arikayce |
| Electromed, INC. | $53.46 | 2023-2025 | Smartvest |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $53.25 | 2025 | Ohtuvayre |
| Harmony Biosciences LLC | $52.81 | 2022-2023 | Wakix |
| Mylan Specialty L.P. | $37.21 | 2024 | Yupelri |
| Pfizer INC. | $32.39 | 2023-2024 | |
| Paratek Pharmaceuticals, INC. | $32.14 | 2025 | Nuzyra |
| Lilly USA, LLC | $29.65 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $21.06 | 2024 | Aralast |
| Forte Bio-Pharma LLC | $18.04 | 2025 | Prolate, Nalocet, Tanlor |
| Baxter Healthcare | $17.89 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Aimmune Therapeutics, INC. | $17.12 | 2023 | |
| Almatica Pharma LLC | $16.19 | 2025 | Teriparatide |
| Genentech USA, INC. | $15.92 | 2024 | Xolair |
| Xeris Pharmaceuticals, INC. | $14.21 | 2025 | Gvoke Hypopen |
| Teva Pharmaceuticals USA, INC. | $13.75 | 2023 | |
| Phathom Pharmaceuticals, INC. | $12.90 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lillian Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.